STIM

NASDAQ Healthcare

Neuronetics, Inc. - Common Stock

Medical Devices

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

๐Ÿ“Š Market Data
Price$1.78
Volume11,791,572
Market Cap123.87M
Beta1.060
RSI (14-Day)80.7 Overbought
200-Day MA$1.72
50-Day MA$1.43
52-Week High$4.85
52-Week Low$0.80
Forward P/E-5.29
Price / Book9.32
๐ŸŽฏ Investment Strategy Scores

STIM scores across each investment strategy. Higher is better for that strategy's goals.

High dividend yield + low volatility
High growth potential (high beta + oversold)
Contrarian plays (oversold + below moving average)
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐ŸŽˆ Over-Hyped (95/100) โ€” this strategy Overbought stocks (potential short candidates).

Lowest fit among scored strategies: ๐Ÿ‹ Institutional Whale (1/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find STIM in your text

Paste any article, transcript, or post โ€” the tool will extract STIM and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-07-16.